Literature DB >> 15495141

Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.

Xianquan Zhan1, Dominic M Desiderio.   

Abstract

This article will review the published research on the elucidation of the mechanisms of pituitary adenoma formation. Mass spectrometry (MS) plays a key role in those studies. Comparative proteomics has been used with the long-term goal to locate, detect, and characterize the differentially expressed proteins (DEPs) in human pituitary adenomas; to identify tumor-related and -specific biomarkers; and to clarify the basic molecular mechanisms of pituitary adenoma formation. The methodology used for comparative proteomics, the current status of human pituitary proteomics studies, and future perspectives are reviewed. The methodologies that are used in comparative proteomics studies of human pituitary adenomas are readily exportable to other different areas of cancer research. (c) 2004 Wiley Periodicals, Inc., Mass Spec Rev 24:783-813, 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15495141     DOI: 10.1002/mas.20039

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  14 in total

1.  Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.

Authors:  Xianquan Zhan; Yuda Huang; Ying Long
Journal:  J Vis Exp       Date:  2018-04-02       Impact factor: 1.355

2.  Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry.

Authors:  Yingchao Liu; Jinsong Wu; Guoquan Yan; Ruiping Hou; Dongxiao Zhuang; Luping Chen; Qi Pang; Jianhong Zhu
Journal:  Proteome Sci       Date:  2010-01-29       Impact factor: 2.480

3.  Signaling pathway networks mined from human pituitary adenoma proteomics data.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2010-04-28       Impact factor: 3.063

Review 4.  Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine.

Authors:  Siqi Wen; Chunling Li; Xianquan Zhan
Journal:  EPMA J       Date:  2022-02-17       Impact factor: 6.543

5.  Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.

Authors:  Xianquan Zhan; Xiaowei Wang; Ying Long; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2014-12-24       Impact factor: 3.063

6.  EPMA position paper in cancer: current overview and future perspectives.

Authors:  Godfrey Grech; Xianquan Zhan; Byong Chul Yoo; Rostyslav Bubnov; Suzanne Hagan; Romano Danesi; Giorgio Vittadini; Dominic M Desiderio
Journal:  EPMA J       Date:  2015-04-15       Impact factor: 6.543

Review 7.  Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.

Authors:  Xianquan Zhan; Xiaowei Wang; Tingting Cheng
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-31       Impact factor: 5.555

8.  The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

Review 9.  Pituitary adenoma nitroproteomics: current status and perspectives.

Authors:  Xianquan Zhan; Xiaowei Wang; Dominic M Desiderio
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

10.  Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.

Authors:  Rong Hu; Xiaowei Wang; Xianquan Zhan
Journal:  EPMA J       Date:  2013-01-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.